CSL Behring - Prof. Heimburger Award
Research Grant - Coagulation
CSL Behring is committed to supporting progress in the area of coagulation. Based on recent publications and feedback from the medical community, allowing the next generation of coagulation specialists to medically and scientifically establish themselves, it is important to ensure continued progress in this therapeutic area. CSL Behring will fund a fourth cycle of a global grant programme to support the above objective.
Prof. Dr. Norbert Heimburger
Professor Dr. Norbert Heimburger, a CSL Behring employee for over three decades, devoted his work to blood coagulation. During that time, he characterised and purified a large number of plasma proteins and was instrumental in making these available to the medical community as therapeutic options. One of his major contributions in this area was the development of virus-inactivated products based on pasteurisation. Due to his determination and his constant interaction with leading haemophilia and coagulation specialists, Behring launched the first effectively virus-inactivated FVIII concentrate in 1981. Professor Dr. Heimburger, honoured with the Order of Merit of the Federal Republic of Germany in 1991, retired in 1991 but was still very much involved with CSL Behring as a Scientific Advisor until he passed away in September 2006.
Grant Details & Eligibility
CSL Behring will set up 5 global start-up grants of 20,000 euros each for the 2011 cycle. The grants are targeted at young investigators, who hold a medical degree. Applicants with less than 5 years experience in haemostasis will be preferred. No matching funding is a prerequisite for this grant. The grants will be available for clinical and/or preclinical research in the area of coagulation.
Application Procedures
Application forms can either be downloaded via the following link:
Application form
or obtained from the following address:
Medical Department
CSL Behring UK Ltd
Hayworth House
Haywards Heath
West Sussex
RH16 1DB
T: +44(0)1444 447 400
For enquiries regarding application, policy and procedures, please do not hesitate to contact us.
Applications consisting of application form, short CV and research proposal (one-pager) must be
postmarked by
8th October 2010
to be considered for the next cycle. Applications
should be submitted to the address above.
All applications will be forwarded to a selection committee consisting of four scientifically renowned clinicians in the field of coagulation:
Thomas Abshire, MD
BloodCenter of Wisconsin, Milwaukee, USA
David Lillicrap, MD
Department of Pathology and Molecular Medicine,
Queen’s University, Kingston, Canada
Claude Négrier, MD
Centre Régional de Traitement de L’Hemophilie,
Hopital Edouard Herriot, Lyon, France
Johannes Oldenburg, MD
Institute of Experimental Haematology
and Transfusion Medicine,
University Clinic Bonn, Bonn, Germany
The selection committee will review applications solely based on scientific merit. CSL Behring will notify the recipients in February 2011. The grants will be personally awarded at the CSL Behring - Prof. Heimburger Award Symposium in Marburg, Germany. All winners will be invited to present their supported projects to the Selection Committee. They will also meet previous winners and benefit from this global exchange platform for haemostasis among upcoming researchers.